Evidence map›Paper›PMID 39132334›Full record

ArticleCirculation reports2024

R

Madoka Sano, Misa Takegami, Masashi Amano, Hidekazu Tanaka, Kenji Ando, Takeshi Kitai, Makoto Miyake, Tatsuhiko Komiya, Masaki Izumo, Hiroya Kawai and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Madoka SanoDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital Kobe Japan.
Misa TakegamiDepartment of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center Osaka Japan.
Masashi AmanoDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Hidekazu TanakaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine Kobe Japan.
Kenji AndoDepartment of Cardiology, Kokura Memorial Hospital Kitakyushu Japan.
Takeshi KitaiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Makoto MiyakeDepartment of Cardiology, Tenri Hospital Nara Japan.
Tatsuhiko KomiyaDepartment of Public Cardiovascular Surgery, Kurashiki Central Hospital Okayama Japan.
Masaki IzumoDivision of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine Kawasaki Japan.
Hiroya KawaiDepartment of Cardiology, Hyogo Prefectural Harima Himeji General Medical Center Hyogo Japan.
Kiyoyuki EishiDepartment of Cardiovascular Surgery, Nagasaki University Hospital Nagasaki Japan.
Kiyoshi YoshidaDepartment of Cardiology, The Sakakibara Heart Institute of Okayama Okayama Japan.
Takeshi KimuraDivision of Cardiology, Hirakata Kohsai Hospial Osaka Japan.
Ryuzo NawadaDepartment of Cardiology, Shizuoka City Shizuoka Hospital Shizuoka Japan.
Tomohiro SakamotoDivision of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center Kumamoto Japan.
Yoshisato ShibataDepartment of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center Miyazaki Japan.
Toshihiro FukuiDepartment of Cardiovascular Surgery, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
Kenji MinatoyaDepartment of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University Kyoto Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
Yasushi SakataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine Osaka Japan.
Kumiko SugioDepartment of Primary Medical Science, Daiichi Sankyo Co., Ltd Tokyo Japan.
Tadaaki KoyamaDepartment of Cardiovascular Surgery, Kansai Medical University Osaka Japan.
Tomoyuki FujitaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center Osaka Japan.
Kunihiro NishimuraDepartment of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center Osaka Japan.
Chisato IzumiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center Osaka Japan.
Yutaka FurukawaDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital Kobe Japan.
BPV-AF Registry Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There are few studies evaluating the prognostic prediction method in atrial fibrillation (AF) patients after bioprosthetic valve (BPV) replacement. The R Methods and Results: The BPV-AF, an observational, multicenter, prospective registry, enrolled AF patients who underwent BPV replacement. The primary outcome measure was a composite of stroke, systemic embolism, CV events including heart failure requiring hospitalization, and cardiac death. A total of 766 patients was included in the analysis. The mean R Conclusions: The R

Indexed as

Atrial fibrillationBioprosthetic valve replacementR2-CHA2DS2-VASc scoreRisk stratification

Identifiers

PMID39132334
PMCPMC11309778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.